By — Laura Santhanam Laura Santhanam Leave a comment 0comments Share Copy URL https://www.pbs.org/newshour/health/watch-live-covid-19-vaccine-manufacturers-describe-how-they-will-ramp-up-supplies Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter WATCH: COVID-19 vaccine manufacturers describe how they will ramp up supplies Health Feb 23, 2021 9:59 AM EDT Five COVID-19 vaccine manufacturers are expected to testify before Congress Tuesday about how they will ramp up vaccine production after more than 500,000 Americans have died from the coronavirus. Watch the testimony stream live in the video player above starting at 10:30 a.m. ET. Officials from AstraZeneca, Johnson & Johnson, Moderna, Novavax and Pfizer are slated to tell the House Energy and Commerce Oversight and Investigations panel what they will do to help produce more vaccine doses and prevent further spread of the coronavirus. New infections, hospitalizations and deaths in the U.S. are declining to rates seen last year, according to Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, during the White House COVID-19 Task Force Monday. But the emergence of coronavirus variants complicates the nation’s response and lends greater urgency to get more people vaccinated, Walensky said. So far, more than 44 million people have received at least one vaccine dose, according to latest CDC data. We're not going anywhere. Stand up for truly independent, trusted news that you can count on! Donate now By — Laura Santhanam Laura Santhanam Laura Santhanam is the Health Reporter and Coordinating Producer for Polling for the PBS NewsHour, where she has also worked as the Data Producer. Follow @LauraSanthanam @LauraSanthanam
Five COVID-19 vaccine manufacturers are expected to testify before Congress Tuesday about how they will ramp up vaccine production after more than 500,000 Americans have died from the coronavirus. Watch the testimony stream live in the video player above starting at 10:30 a.m. ET. Officials from AstraZeneca, Johnson & Johnson, Moderna, Novavax and Pfizer are slated to tell the House Energy and Commerce Oversight and Investigations panel what they will do to help produce more vaccine doses and prevent further spread of the coronavirus. New infections, hospitalizations and deaths in the U.S. are declining to rates seen last year, according to Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, during the White House COVID-19 Task Force Monday. But the emergence of coronavirus variants complicates the nation’s response and lends greater urgency to get more people vaccinated, Walensky said. So far, more than 44 million people have received at least one vaccine dose, according to latest CDC data. We're not going anywhere. Stand up for truly independent, trusted news that you can count on! Donate now